RANTES gene polymorphisms (-403G>A and -28C>G) associated with hepatitis B virus infection in a Saudi population

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 855-862

  Al Qahtani, A ^a,b   Alarifi, S ^b,c   Al Okail, M ^b,c   Hussain, Z ^b   Abdo, A ^b,d   Sanai, F ^b,e   Al Anazi, M ^a   Khalaf, N ^a   Al Humaidan, H ^a   Al Ahdal, M ^a   Almajhdi, F N ^b,c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

Author keywords

Gene polymorphisms; Hepatitis B virus; RANTES; Saudi Arabia

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; RANTES;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MUTATOR GENE; REGULATED ON ACTIVATION NORMAL T CELL EXPRESSED AND SECRETED FACTOR GENE; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

EID: 84930475624     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.April.10.1     Document Type: Article

References (28)

1. Ahn SH, Kim DY, Chang HY, Hong SP, et al. (2006). Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J. Med. Virol. 78: 1564-1571.
2. Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, et al. (2007). CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am. J. Pathol. 170: 1975-1988.
3. An P, Nelson GW, Wang L, Donfield S, et al. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. U. S. A. 99: 10002-10007.
4. Bowen DG and Walker CM (2005). Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201: 1709-1714.
5. Bracci PM, Skibola CF, Conde L, Halperin E, et al. (2010). Chemokine polymorphisms and lymphoma: a pooled analysis. Leuk. Lymphoma 51: 497-506.
6. Centi S, Negrisolo S, Stefanic A, Benetti E, et al. (2010). Upper urinary tract infections are associated with RANTES promoter polymorphism. J. Pediatr. 157: 1038-1040.
7. Cheong JY, Cho SW, Choi JY, Lee JA, et al. (2007). RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J. Korean Med. Sci. 22: 529-535.
8. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, et al. (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
9. Duan ZP, Zhao XY, Huang DZ, He LX, et al. (2005). RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection. Chin. Med. J. 118: 909-914.
10. Durantel D and Zoulim F (2009). Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology 50: 1692-1695.
11. Gonzalez E, Rovin BH, Sen L, Cooke G, et al. (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. U. S. A. 99: 13795-13800.
12. Grakoui A, Shoukry NH, Woollard DJ, Han JH, et al. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
13. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, et al. (2003). Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38: 1468-1476.
14. Hizawa N, Yamaguchi E, Konno S, Tanino Y, et al. (2002). A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am. J. Respir. Crit. Care Med. 166: 686-690.
15. Lee WM (1997). Hepatitis B virus infection. N. Engl. J. Med. 337: 1733-1745.
16. Liu H, Chao D, Nakayama EE, Taguchi H, et al. (1999). Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl. Acad. Sci. U. S. A. 96: 4581-4585.
17. Ma K, Xu W, Shao X, Yanyue, et al. (2007). Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells. Antiviral Res. 76: 140-149.
18. Nam SH, Park JH, Kang JH, Kang SY, et al. (2006). Modulation of immune response induced by co-administration of DNA vaccine encoding HBV surface antigen and HCV envelope antigen in BALB/c mice. Arch. Pharm. Res. 29: 1042-1048.
19. Nelson PJ, Ortiz BD, Pattison JM and Krensky AM (1996). Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J. Immunol. 157: 1139-1148.
20. Ness TL, Carpenter KJ, Ewing JL, Gerard CJ, et al. (2004). CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 173: 6938-6948.
21. Nickel RG, Casolaro V, Wahn U, Beyer K, et al. (2000). Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 164: 1612-1616.
22. Park BL, Kim YJ, Cheong HS, Kim LH, et al. (2006). Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp. Mol. Med. 38: 694-702.
23. Rehermann B, Lau D, Hoofnagle JH and Chisari FV (1996). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 97: 1655-1665.
24. Thio CL, Astemborski J, Thomas R, Mosbruger T, et al. (2008). Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. J. Immunol. 181: 7944-7947.
25. Watson RW (2002). The rising incidence of hepatocellular carcinoma. N. Engl. J. Med. 341: 451-452.
26. Zhang YG, Huang J, Zhang J, Li XB, et al. (2010). RANTES gene polymorphisms and asthma risk: A meta-analysis. Arch. Med. Res. 41: 50-58.
27. Zhao XY, Lee SS, Wong KH, Chan KC, et al. (2004). Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese. Eur. J. Immunogenet. 31: 179-183.
28. Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, et al. (2006). Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun. 7: 544-549.